###begin article-title 0
Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma
###end article-title 0
###begin p 1
Conceived and designed the experiments: AG AKB HA BD. Performed the experiments: AG AKB. Analyzed the data: AG AKB HA BD. Contributed reagents/materials/analysis tools: BL HA. Wrote the paper: AG AKB BL HA BD.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 232 240 <span type="species:ncbi:9606">patients</span>
The molecular biology of renal cell carcinoma (RCC) is complex and not fully understood. We have recently found that the expression of the receptor tyrosine kinase Axl in the RCC tumors independently correlates with survival of the patients.
###end p 3
###begin title 4
Principal Findings
###end title 4
###begin p 5
###xml 111 140 111 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">growth arrest-specific gene 6</italic>
###xml 818 825 814 821 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
Here, we have investigated the role of Axl and its ligand Gas6, the vitamin-K dependent protein product of the growth arrest-specific gene 6, in clear cell RCC (ccRCC) derived cells. The Axl protein was highly expressed in ccRCC cells deficient in functional von Hippel-Lindau (VHL) protein, a tumor suppressor gene often inactivated in ccRCC. VHL reconstituted cells expressed decreased levels of Axl protein, but not Axl mRNA, suggesting VHL to regulate Axl expression. Gas6-mediated activation of Axl in ccRCC cells resulted in Axl phosphorylation, receptor down-regulation, decreased cell-viability and migratory capacity. No effects of the Gas6/Axl system could be detected on invasion. Moreover, in ccRCC tumor tissues, Axl was phosphorylated and Gas6 gamma-carboxylated, suggesting these molecules to be active in vivo.
###end p 5
###begin title 6
Significance
###end title 6
###begin p 7
These results provide novel information regarding the complex function of the Gas6/Axl system in ccRCC.
###end p 7
###begin title 8
Introduction
###end title 8
###begin p 9
###xml 157 160 157 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Schlessinger1">[1]</xref>
###xml 162 165 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Robinson1">[2]</xref>
The receptor tyrosine kinases (RTKs) constitute a superfamily of transmembrane proteins that relays signals from extracellular growth factors into the cell. [1], [2]
###end p 9
###begin p 10
###xml 69 72 69 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Hafizi1">[3]</xref>
###xml 74 77 74 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Linger1">[4]</xref>
###xml 355 384 355 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">growth arrest-specific gene 6</italic>
###xml 384 387 384 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Hafizi2">[5]</xref>
###xml 389 392 389 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-BellidoMartin1">[6]</xref>
###xml 547 550 547 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Manfioletti1">[7]</xref>
###xml 619 622 619 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-AngelilloScherrer1">[8]</xref>
###xml 624 627 624 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Evenas1">[9]</xref>
###xml 753 757 753 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Goruppi1">[10]</xref>
The TAM subfamily of RTKs contains the receptors Axl, Tyro3, and Mer [3], [4]. They have in common a unique extracellular domain composed of two N-terminal immunoglobulin-like domains and two fibronectin type III repeats similar to the structure of neural cell adhesion molecules (NCAMs). The TAM receptors share the same ligand, Gas6, the product of the growth arrest-specific gene 6[5], [6]. Gas6, cloned from serum-starved fibroblasts, is a member of the vitamin K-dependent family of Gla proteins homologous to the blood coagulation protein S [7]. However, Gas6 is not believed to harbor any coagulation properties [8], [9]. Instead, Gas6 in general serve as a mitogen and survival factor that protects cells from serum starvation-induced apoptosis [10].
###end p 10
###begin p 11
###xml 122 125 122 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Linger1">[4]</xref>
###xml 241 245 241 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-OBryan1">[11]</xref>
###xml 247 251 247 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Janssen1">[12]</xref>
###xml 317 324 317 324 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Janssen1">[12]</xref>
###xml 440 444 440 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Craven1">[13]</xref>
###xml 453 457 453 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Berclaz1">[14]</xref>
###xml 466 470 466 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Hutterer1">[15]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Ito1">[16]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Sawabu1">[17]</xref>
###xml 509 513 509 513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Quong1">[18]</xref>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Shieh1">[19]</xref>
###xml 567 571 567 571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 695 699 695 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Vajkoczy1">[21]</xref>
###xml 808 812 808 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Holland1">[22]</xref>
###xml 179 184 <span type="species:ncbi:9606">human</span>
###xml 406 411 <span type="species:ncbi:9606">human</span>
Adequate evidence supports the role of the Gas6/Axl system in driving cell growth and survival in normal and cancer cells [4]. Axl was originally cloned as a transforming gene in human chronic myeloid leukemia and myeloproliferative disease [11], [12], and shown to transform NIH3T3 cells and render them tumorigenic in vivo[12]. Since then, Axl overexpression and signaling has been implicated in several human malignancies, such as colon [13], breast [14], glioma [15], thyroid [16], gastric [17], melanoma [18], lung cancer [19], and in renal cell carcinoma (RCC) [20]. A more detailed role of Axl biology has been proven in glioma, where loss of Axl signaling diminished glioma tumor growth [21], and in breast cancer, where Axl drive cell migration, tube formation, neovascularization, and tumor growth [22].
###end p 11
###begin p 12
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 100 108 <span type="species:ncbi:9606">patients</span>
###xml 205 212 <span type="species:ncbi:9606">patient</span>
###xml 236 244 <span type="species:ncbi:9606">patients</span>
Recently, we have seen that Axl and Gas6 expression correlates to survival in a large cohort of RCC patients [20]. Interestingly, we found low Axl mRNA to independently correlate with substantially longer patient survival. Furthermore, patients with low Axl and high Gas6 mRNA levels as a combination had further increased survival.
###end p 12
###begin p 13
###xml 240 257 240 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">von Hippel-Lindau</italic>
###xml 629 633 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Ljungberg1">[23]</xref>
###xml 635 639 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Cohen1">[24]</xref>
RCC is a common tumor of the kidney with poor prognosis. Several RCC tumor types are present based on different histopathological and specific genetic variations. Clear cell RCC (ccRCC) represents the majority of RCCs and alteration in the von Hippel-Lindau (VHL) tumor suppressor gene is one of the most common genetic alterations occurring in about 80% of these cases. The VHL protein function as an ubiquitin ligase and targets the hypoxia inducible transcription factors HIF-1alpha and HIF-2alpha for degradation. Loss of VHL function leads to a pseudo-hypoxic response in ccRCC that conveys much of the disease progression. [23], [24]
###end p 13
###begin p 14
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 109 113 109 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Fiebeler1">[25]</xref>
###xml 115 119 115 119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Arai1">[26]</xref>
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Nagai1">[27]</xref>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Yanagita2">[29]</xref>
In the kidney, Gas6 and Axl are mainly expressed in glomeruli, tubular endothelial and mesangial cells [20], [25], [26] and Gas6 functions as an Axl-specific autocrine growth factor in mesangial cells [27]-[29].
###end p 14
###begin p 15
In the present investigation, we used a cell based RCC model system in order to explore the complex role of Gas6 and Axl in RCC. Our results contribute to the understanding of the multifaceted molecular biology of the disease.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Active Axl/Gas6 System in ccRCC Tissue Biopsies
###end title 17
###begin p 18
###xml 166 167 166 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 160 167 160 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>A</italic></xref>
###xml 250 254 250 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Varnum1">[30]</xref>
###xml 390 394 390 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-OBryan1">[11]</xref>
###xml 396 400 396 400 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-OBryan2">[31]</xref>
###xml 475 476 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 469 476 469 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>A</italic></xref>
###xml 573 574 573 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 567 574 567 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>A</italic></xref>
###xml 897 898 897 898 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 891 898 891 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>A</italic></xref>
###xml 76 83 <span type="species:ncbi:9606">patient</span>
###xml 449 454 <span type="species:ncbi:9606">human</span>
Axl was present in homogenized tissue lysates from a panel of matched ccRCC patient biopsies and their respective unaffected kidney cortex tissue counterparts (Fig. 1A). Since Axl phosphorylation and activation occurs upon binding of its ligand Gas6 [30], we investigated the phosphorylation status of Axl in the biopsies. All three known Axl glycosylation isoforms (140, 120, and 104 kDa) [11], [31] were phosphorylated with various intensities in human ccRCC tissue (Fig. 1A; upper panel). Interestingly, compared to total amount of Axl protein immunoprecipitated (Fig. 1A; lower panel), the level of phosphorylation in the different biopsies varied extensively. Some biopsies with low Axl protein had very high phosphorylation status, e.g., lane seven, and vice versa, some biopsies with high Axl protein expression showed no or low phosphorylation level, e.g., lane two, three, and six (Fig. 1A).
###end p 18
###begin title 19
###xml 56 61 <span type="species:ncbi:9606">human</span>
Axl is phosphorylated and Gas6 is gamma-carboxylated in human ccRCC tissue.
###end title 19
###begin p 20
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 162 163 162 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 41 48 <span type="species:ncbi:9606">patient</span>
###xml 833 840 <span type="species:ncbi:9606">patient</span>
Homogenized tissue lysates from a panel (patient one to eight) of matched ccRCC tissues and unaffected kidney cortex counterparts were used for Axl (A) and Gas6 (B) immunoprecipitation with specific polyclonal antisera (#R042 towards Axl N-terminal; #005 towards Gas6) containing 50-100 microg total immunoglobulin molecules (about 0.5-1.0 microg specific immunoprecipitating antibody). Pellets were separated on a 6% denaturing SDS-PAGE gel. Protein expression and posttranslational modifications were verified with western blot analysis using Axl (Axl-C20; towards Axl C-terminal), Gas6 (R&D), phosphotyrosine (PY99) and Gla (M3b; 5 mM EDTA final) specific antibodies, respectively. Membranes were first immunoblotted for phosphotyrosine and Gla, respectively, and thereafter stripped and reprobed for total Axl and Gas6. For each patient the matched samples are denoted: N (normal unaffected kidney cortex) and T (ccRCC tissue). Absolute concentrations in the lysates measured by ELISA are depicted below each sample.
###end p 20
###begin p 21
###xml 135 139 131 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Hasanbasic1">[32]</xref>
###xml 295 302 283 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 310 311 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 304 311 292 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>B</italic></xref>
Moreover, since Gas6 ligand only is functional and can stimulate Axl properly when correctly gamma-carboxylated processed by Vitamin K [32], we examined whether Gas6 was present and gamma-carboxylated in the matched ccRCC biopsies. We found Gas6 to be expressed and correctly gamma-carboxylated in vivo (Fig. 1B).
###end p 21
###begin p 22
###xml 172 175 172 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,B</italic>
###xml 166 175 166 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>A,B</italic></xref>
###xml 445 448 441 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A,B</italic>
###xml 439 448 435 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g001">Fig. 1<italic>A,B</italic></xref>
We also measured absolute expression levels of Axl and Gas6 in the different biopsies using specific ELISA assay, and the concentrations are given below each figure (Fig. 1A,B). Since the immunoprecipitating antibody was the limiting step (about 0.5-1 microg specific immunoprecipitating antibody) the various Axl and Gas6 concentrations detected by the ELISA assays could not be reflected by the levels detected on western blot analysis (Fig. 1A,B).
###end p 22
###begin title 23
Axl and Gas6 Expression in ccRCC 786-O Cells
###end title 23
###begin p 24
###xml 332 333 332 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 326 333 326 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g002">Fig. 2<italic>A</italic></xref>
###xml 476 477 476 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 470 477 470 477 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g002">Fig. 2<italic>B</italic></xref>
###xml 686 693 686 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007575-t001">Table 1</xref>
###xml 864 871 864 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007575-t001">Table 1</xref>
###xml 999 1003 999 1003 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 1245 1252 1245 1252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007575-t001">Table 1</xref>
In our attempt to study the biological role of Gas6 and Axl signaling in a cell based model system, we first verified the expression and functionality of Axl and Gas6 in the ccRCC 786-O cell line deficient in the VHL tumor suppressor protein. Western blot analysis showed high expression levels of Axl protein in these cells (Fig. 2A). However, no Gas6 protein could be found neither with western blot on total cell lysate (data not shown) nor with immunoprecipitation (Fig. 2B). In contrast to the results obtained using western blotting, a weak expression of Gas6 mRNA in the same range as that of Gas6 mRNA in ccRCC tumor could be detected using quantitative real-time PCR (qRT-PCR; Table 1). The quantity of Axl mRNA in 786-O cells was very high relative to Gas6 mRNA levels and relative to Axl mRNA levels in the pair of matched normal and tumor RCC tissues (Table 1). The relative expression of Axl mRNA was as high as seen in the limited number of ccRCC tumors analyzed in our previous study [20]. By employing VHL reconstituted 786-O cells we were able to clarify the impact of functional VHL on Axl and Gas6 expression. No difference in mRNA levels could be detected in the three 786-O subclones (786-O wt, mock, and VHL reconstituted; Table 1).
###end p 24
###begin title 25
Axl but not Gas6 is expressed in ccRCC 786-O cells and can be functionally active.
###end title 25
###begin p 26
###xml 19 20 19 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 32 33 32 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 404 408 404 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Stenhoff1">[51]</xref>
###xml 558 559 558 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 611 612 611 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
Expression of Axl (A) and Gas6 (B) were analyzed by western blot analysis using total cell lysate (tcl; Axl) and immunoprecipitate (Gas6) separated on an 8% reducing SDS-PAGE gel, and using Axl (Axl-C20) and Gas6 (R&D) specific antibodies, respectively. Gas6 expression in 786-O cells, grown in conditioned medium with and without vitamin K, was compared to expression in stably transfected Hek293 cells [51]. Gas6-dependent Axl phosphorylation was analysed in serum-starved (1% FCS; 20 h) 786-O cells stimulated with various Gas6 concentrations for 10 min (C) and stimulated with 400 ng/mL Gas6 for up to 1 h (D). Total cell lysate of stimulated cells were subjected to Axl immunoprecipitation with an in house Axl-specific polyclonal antibody (R042) and immune-complexes were thereafter separated on 8% reducing SDS-PAGE and immunoblotted for phosphorylated Axl (PY99). The membranes were stripped and reblotted for total amount of immunoprecipitated Axl (Axl-C20). Representative western blots are shown.
###end p 26
###begin title 27
Gas6 and Axl mRNA expression in a ccRCC kidney and cell line.
###end title 27
###begin p 28
###xml 32 37 <span type="species:ncbi:9606">human</span>
qRT-PCR measurement relative to human beta2-microglobulin reference gene.
###end p 28
###begin p 29
786-O wt, mock and VHL refers to ccRCC 786-O cells that are not transfected (defective VHL), empty vector transfected (defective VHL) and VHL reconstituted (functional VHL), respectively.
###end p 29
###begin title 30
Gas6 Induces Axl Phosphorylation in ccRCC 786-O Cells
###end title 30
###begin p 31
###xml 333 336 333 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C,D</italic>
###xml 327 336 327 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g002">Fig. 2<italic>C,D</italic></xref>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 452 459 452 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g002">Fig. 2<italic>C</italic></xref>
###xml 689 690 689 690 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 683 690 683 690 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g002">Fig. 2<italic>D</italic></xref>
###xml 963 972 963 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007575.s001">Figure S1</xref>
###xml 972 973 972 973 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 1048 1057 1048 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007575.s001">Figure S1</xref>
###xml 1057 1058 1057 1058 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 1235 1244 1235 1244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0007575.s001">Figure S1</xref>
###xml 1244 1245 1244 1245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
In order to verify functionality of our model system, the ability of Gas6 to bind and activate Axl was determined by evaluating the ligand-dependent phosphorylation of Axl in 786-O cells. Gas6 stimulated cells showed phosphorylated Axl, while TBS control treated cells show no or markedly low basal Axl phosphorylation levels (Fig. 2C,D). Using 400 ng/mL of Gas6 yielded saturated Axl phosphorylation levels (compared to higher concentrations of Gas6; Fig. 2C). Lower doses of Gas6 stimulation resulted in Axl phosphorylation displaying a dose-response relationship (data not shown). Gas6 stimulation timecourse revealed a peak of phosphorylated Axl levels between 5 and 10 minutes (Fig. 2D). Notably, there was a 2-fold higher induction level of Gas6-dependent Axl phosphorylation in cells grown in 1% FCS compared to cells grown in 10% FCS (data not shown). Furthermore, we found a modest increase in phosphorylated Erk levels after 10 min of Gas6 stimulation (Figure S1B). No influence of Gas6 stimulation on Akt phosphorylation could be found (Figure S1A). Intriguingly, our preliminary results suggested a dip in total Akt levels at 20 min of Gas6 stimulation, which was a consistent observation that we currently cannot explain (Figure S1A).
###end p 31
###begin title 32
Gas6 Inhibits Migration and Cell-Viability of ccRCC 786-O Cells Mediated through Axl
###end title 32
###begin title 33
Migration
###end title 33
###begin p 34
###xml 259 260 259 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 253 260 253 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g003">Fig. 3<italic>A</italic></xref>
To examine the effect of Gas6 stimulation on 786-O cell migration, the chemotaxis-based Boyden chamber migration assay was employed. A significant decrease in migration was seen after 4 h of stimulation with 400 ng/mL Gas6 compared to mock stimulation (Fig. 3A).
###end p 34
###begin title 35
Gas6-dependent Axl-mediated inhibition of ccRCC 786-O cell migration.
###end title 35
###begin p 36
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 362 363 362 363 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 389 409 389 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">material and methods</xref>
###xml 412 413 412 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 741 747 741 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g003">Fig. 3</xref>
###xml 747 750 747 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B,C</italic>
The migratory capacity of 786-O cells upon Gas6 stimulation was analyzed using the Boyden chamber assay. (A) Gas6 stimulation (400 ng/mL) for 4 h decreases the migratory capacity of 786-O cells to about 80% in comparison to that of mock treated cells. Verification of the Axl knockdown using siAxl and siSCR treated cells by either (B) western blot analysis or (C) qRT-PCR as described in material and methods. (D) The inhibition of migration due to Gas6 stimulation was a consequence of ligand specific activation of the Axl receptor as confirmed by repeating the migration experiment using the siAxl and siSCR treated 786-O cells. Each experiment was conducted in triplicates, and the result out of three independent experiments is shown. Fig. 3B,C shows results from one representative experiment.
###end p 36
###begin p 37
###xml 448 449 448 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 442 449 442 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g003">Fig. 3<italic>B</italic></xref>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 562 569 562 569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g003">Fig. 3<italic>C</italic></xref>
###xml 727 728 727 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 721 728 721 728 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g003">Fig. 3<italic>D</italic></xref>
###xml 834 840 834 840 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
###xml 909 910 909 910 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</italic>
###xml 903 910 903 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g003">Fig. 3<italic>D</italic></xref>
In order to verify that the Gas6-dependent decrease of migration was due to specific ligation and activation of the Axl receptor by Gas6 we performed the migration experiment using Axl knockdown cells. The abrogation of the Axl protein expression was performed using Axl silencing RNA (siAxl). Axl protein expression was undetectable by western blot analysis after silencing compared to control cells transfected with scrambled siRNA (siSCR; Fig. 3B). The mRNA levels of the Axl transcript was decreased to approximately 7% of that of control transfected cells (Fig. 3C). Gas6 stimulation (400 ng/mL) of Axl-knockdown cells yielded no significant difference in migratory capacity compared to mock-stimulated siAxl cells (Fig. 3D), verifying that the Gas6-dependent inhibitory effect was mediated through the Axl receptor and that Axl per se does not contribute to the migratory capacity of 786-O cells (Fig. 3D).
###end p 37
###begin title 38
Viability
###end title 38
###begin p 39
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 334 341 334 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g004">Fig. 4<italic>A</italic></xref>
Using the tetrazole 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, we examined the metabolic activity as an estimation of 786-O cell-viability after stimulation with Gas6. A modest but clear decrease in viability was seen after 24 h of Gas6 stimulation (400 ng/mL) compared to TBS control stimulated cells (Fig. 4A). Knockdown of Axl expression did not by itself affect the viability of 786-O cells (data not shown).
###end p 39
###begin title 40
Gas6-dependent Axl-mediated effects on ccRCC 786-O cell viability and invasion.
###end title 40
###begin p 41
###xml 61 62 61 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 206 207 206 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 380 381 380 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 398 404 398 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">per se</italic>
Viability of 786-O cells were analysed using the MTT assay. (A) Stimulation of 786-O cells with 400 ng/mL Gas6 for 24 h resulted in a viability of about 80% in comparison to that of control treated cells. (B) Invasion of 786-O cells using the modified Boyden chamber assay with a matrigel layer for analysis of invasive capacity was not affected by Gas6 stimulation (400 ng/mL). (C) Axl expression per se did not contribute to the high invasive phenotype of 786-O cells, since the lack of Axl expression did not result in any significant diminished invasive capacity. Each experiment was performed using at least triplicates and the result is shown from three independent experiments.
###end p 41
###begin title 42
Invasiveness of ccRCC 786-O Is Independent of the Gas6/Axl System
###end title 42
###begin p 43
###xml 363 364 363 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 357 364 357 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g004">Fig. 4<italic>B</italic></xref>
###xml 448 452 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Sawabu1">[17]</xref>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Vajkoczy1">[21]</xref>
###xml 482 486 482 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Tai1">[33]</xref>
###xml 702 703 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 696 703 696 703 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g004">Fig. 4<italic>C</italic></xref>
We wanted to investigate the role of Axl in the mechanism of invasion of 786-O cells, known to have high invasive potency. For this purpose, we used the modified Boyden chamber assay in which the cells have to invade a matrigel layer. We could not detect any effect of Gas6 stimulation on the invasive phenotype of 786-O cells in comparison to TBS control (Fig. 4B). Since it is previously shown that Axl mediates invasion both in a Gas6-dependent [17], [21] and independent manner [33], we investigated the invasive phenotype of Axl knockdown 786-O cells. However, we could not detect any significant decrease of invasion of cells where Axl RTK expression was silenced compared to normal cells (Fig. 4C).
###end p 43
###begin title 44
Regulation of Axl Protein Expression in ccRCC 786-O Cells
###end title 44
###begin title 45
Gas6-dependent Axl downregulation
###end title 45
###begin p 46
###xml 407 408 407 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 401 408 401 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g005">Fig. 5<italic>A</italic></xref>
Stimulation of 786-O cells with 400 ng/mL Gas6 for up to 6 h resulted in a time-dependent down-regulation of Axl protein. After 6 h of Gas6 stimulation, the expression of Axl protein was almost undetectable by western blot analysis (data not shown). The amount of Axl protein was significantly decreased after 6 h of stimulation compared to the first time-point and compared to mock stimulated cells (Fig. 5A).
###end p 46
###begin title 47
Gas6- and VHL-dependent Axl protein expression in ccRCC 786-O cells.
###end title 47
###begin p 48
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</italic>
###xml 553 554 550 551 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 691 692 688 689 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1131 1132 1125 1126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
(A) Serum-starved 786-O cells (1% FCS; 20 h) were stimulated with 400 ng/mL Gas6 or mock control for up to 6 h. Gas6-dependendent Axl protein down-regulation over time were verified with western blot analysis on total cell lysate from treated cells using 8% reducing SDS-PAGE. Membranes were immunoblotted with Axl specific antibodies (Axl-C20) and reprobed with beta-actin specific antibodies (A5441) for relative quantification of Axl expression levels. Each experiment was run in duplicates and the result of three independent experiments is shown. (B) Axl expression in 786-O mock (VHL defective) or VHL reconstituted cells was analyzed in cells grown in either normoxia or hypoxia (1% O2) under serum starvation (1% FCS) for 48 h. VHL-dependent Axl expression was verified using western blot analysis of total cell lysates of treated cells that were separated on an 8% reducing SDS-PAGE gel. Membranes were immunoblotted with Axl-specific antibodies (Axl-C20) and with beta-actin specific antibodies (A5441) for relative quantification of Axl expression levels. The experiment was carried out using a minimum of triplicates. (C) Axl inverse correlation to functional VHL protein was further analyzed by immunoblotting for Axl expression in total cell lysates of a panel of ccRCC cell lines with different VHL status. Equal amounts of total protein were separated on an 8% reducing SDS-PAGE gel and membrane immunoblotted with Axl-specific antibodies (Axl-C20).
###end p 48
###begin title 49
Axl protein level is inversely related to VHL expression
###end title 49
###begin p 50
###xml 12 19 12 19 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007575-t002">Table 2</xref>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</italic>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g005">Fig. 5<italic>B</italic></xref>
###xml 680 684 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Maxwell1">[34]</xref>
###xml 686 690 678 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Hu1">[35]</xref>
###xml 800 804 792 796 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Fogh1">[36]</xref>
###xml 884 885 876 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</italic>
###xml 878 885 870 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0007575-g005">Fig. 5<italic>C</italic></xref>
As shown in Table 2 Axl mRNA levels was not affected by introduction of wt VHL in the VHL deficient 786-O cells. In contrast, when Axl protein levels were assessed in the 786-O subclones a considerable difference was detected. Axl protein was decreased to about half in VHL reconstituted cells compared to mock transfected or untransfected VHL defective cells. Importantly, the Axl protein levels remained low also when the VHL reconstituted cells were grown at hypoxia (1% oxygen) and hence reactivate the hypoxic response due to stabilization of HIF-2a (Fig. 5B). These results suggest that Axl is not a direct HIF-2alpha gene target (HIF-1alpha is not expressed in 786-O cells [34], [35]) Moreover, Axl protein expression was high in ccRCC cell lines with defective VHL protein compared to Caki-2 [36], a ccRCC cell line with papillary RCC characteristic and functional VHL (Fig. 5C). Together, these results show that loss of VHL is associated with elevated levels of Axl through a yet unknown post-transcriptional mechanism.
###end p 50
###begin title 51
###xml 55 62 <span type="species:ncbi:9606">patient</span>
ccRCC tumor characteristics at time of nephrectomy and patient clinicopathological information.
###end title 51
###begin p 52
###xml 72 76 72 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Sobin1">[53]</xref>
According to the tumor-node-metastasis (TNM) classification system 2002 [53].
###end p 52
###begin p 53
###xml 35 39 35 39 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Skinner1">[54]</xref>
According to Skinner nuclear grade [54].
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 345 349 345 349 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Craven1">[13]</xref>
###xml 350 354 350 354 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Ito1">[16]</xref>
###xml 356 360 356 360 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Shieh1">[19]</xref>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Vajkoczy1">[21]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Sun1">[37]</xref>
###xml 373 377 373 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Zhang1">[38]</xref>
###xml 462 466 462 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Hutterer1">[15]</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Sun1">[37]</xref>
###xml 590 594 590 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-McCormack1">[39]</xref>
###xml 606 610 606 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 236 241 <span type="species:ncbi:9606">human</span>
###xml 570 575 <span type="species:ncbi:9606">human</span>
We demonstrate inhibition of migration and viability in ccRCC 786-O cells as a result of Gas6 signaling through the Axl RTK. However, the highly invasive phenotype of these cells was not affected by the Gas6/Axl system. So far, in most human cancers where the biology of Gas6 and Axl has been studied, Axl is believed to exert oncogenic effects [13]-[16], [19]-[21], [37], [38], and a combined increase of Gas6 and Axl expression correlate with poorer prognosis [15], [37]. Increased Gas6 expression correlating with favorable prognosis has so far only been reported in human breast cancer [39] and in RCC [20], which partly may be explained by mechanisms presented here.
###end p 55
###begin p 56
###xml 153 157 153 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Fridell1">[40]</xref>
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-NielsenPreiss1">[42]</xref>
###xml 227 231 227 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Yanagita1">[28]</xref>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Yanagita2">[29]</xref>
###xml 275 279 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Nagai2">[43]</xref>
###xml 341 345 341 345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Shieh1">[19]</xref>
###xml 347 351 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Zhang1">[38]</xref>
###xml 445 449 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Vajkoczy1">[21]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gallicchio1">[44]</xref>
Our results are in large contradictory to the common picture of Gas6 and Axl signaling. Gas6 has for instance been shown to induce chemotactic migration [40]-[42], to be an autocrine growth factor in glomerular mesangial cells [28], [29], and to drive glomerular hypertrophy [43]. Invasiveness has been correlated with the expression of Axl [19], [38], and Gas6-dependent signaling through Axl has been shown to promote invasion of glioma cells [21]. However, in line with our results, Gas6 has also been shown to have opposing effects by inhibiting VEGFR-A driven migration specifically through the activation of Axl RTK [44].
###end p 56
###begin p 57
###xml 201 205 201 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 417 421 417 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 759 763 759 763 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Bellosta1">[45]</xref>
###xml 765 769 765 769 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Wimmel1">[46]</xref>
###xml 823 830 823 830 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 1085 1089 1085 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Budagian1">[47]</xref>
###xml 408 416 <span type="species:ncbi:9606">patients</span>
Our results together with known literature imply that the biology of Gas6 and Axl is complex and probably context-specific. Perhaps in RCC, where high Gas6 expression correlate with improved prognosis [20], Gas6 can be protective and retard cancer progression by mechanisms, such as decreased migratory potential and decreased viability. High Axl mRNA expression is in itself negative for the outcome of RCC patients [20], and prolonged Gas6 stimulation of 786-O cells leads to protein down-regulation of Axl. However, our present data do not provide an explanation how Axl by itself contribute to poor prognosis. It is possible that the adhesion-like extra cellular region of the Axl receptor with its ability to mediate homophilic interactions and adhesion [45], [46] can contribute to a more aggressive cancer phenotype in vivo independent of Gas6 stimulation. Other putative uncharacterized contributions of Axl in cancer progression can also be discussed. For instance, Axl dependent signal transduction and survival mediated by other heterophilic interactions has been described [47].
###end p 57
###begin p 58
###xml 228 232 228 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Cohen1">[24]</xref>
###xml 694 702 690 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 779 783 775 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Holland1">[22]</xref>
###xml 880 884 876 880 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Bellosta1">[45]</xref>
###xml 1143 1147 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gallicchio1">[44]</xref>
###xml 763 768 <span type="species:ncbi:9606">human</span>
Another key aspect of the pathogenesis of ccRCC is the loss of expression of the tumor suppressor VHL protein resulting in pro-angiogenic stimulus of the cancer cells due to increased expression of VEGF and autocrine signaling. [24] Interestingly, we found an association between expression of Axl protein and the tumor suppressor VHL in 786-O cells. When a functional VHL protein was introduced, Axl protein levels decreased to about half. No difference could be found in Axl mRNA levels. Furthermore, Axl is not a gene target of HIF-2alpha, since there was a VHL dependent downregulation of Axl in cells grown in hypoxia as well. As mentioned, Axl has been shown to affect neovascularization in vitro, and loss of Axl expression in tumor cells blocks growth of human neoplasms [22]. Perhaps, Axl on its own, by homophilic interactions and by a kinase domain-dependent mechanism [45], contribute to the disease-specific angiogenic program during VHL loss in tumor cells in parallel with angiogenic factors such as VEGF. Gas6 signaling via Axl on the other hand has been shown to have inhibitory effects on the VEGFR-driven angiogenic program [44]. One might therefore speculate that at high Axl expression levels, increased Gas6 signaling through Axl could be anti-angiogenic and beneficial. These interesting results indicate that there is a need for further exploration of the role of Axl and Gas6 in regulation of the angiogenic process in ccRCC and moreover, to determine whether VHL function as an Axl-specific ubiquitin ligase or regulates Axl protein expression level by another unknown mechanism.
###end p 58
###begin p 59
Our results demonstrate that the Gas6/Axl system plays a role in RCC, and that Gas6 not always functions as a mitogenic growth factor. Our results lay the ground for further investigation of the complex biology of Axl and Gas6 in RCC and several other diseases where this signaling pathway contribute to the pathological process.
###end p 59
###begin title 60
Materials and Methods
###end title 60
###begin title 61
###xml 0 7 <span type="species:ncbi:9606">Patient</span>
Patient Biopsies
###end title 61
###begin p 62
###xml 283 287 283 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 361 368 361 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0007575-t002">Table 2</xref>
###xml 70 78 <span type="species:ncbi:9606">patients</span>
###xml 191 198 <span type="species:ncbi:9606">patient</span>
###xml 328 336 <span type="species:ncbi:9606">patients</span>
Tumor biopsies and normal kidney cortex tissues were taken from ccRCC patients. The study was approved by the ethical committee of Umea University and by the Institutional Review Board. Each patient participated after providing informed written consent. For detailed information see [20]. Clinicopathological characteristics of patients and tumors are shown in Table 2.
###end p 62
###begin title 63
Cell Culture and Reagents
###end title 63
###begin p 64
###xml 29 33 29 33 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Williams1">[48]</xref>
###xml 253 257 253 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Iliopoulos1">[49]</xref>
The ccRCC cell line 786-O wt [48] (American Type Culture Collection; LGC Standards AB) was maintained in DMEM supplemented with 10% FCS and 1% penicillin and streptomycin and 1% L-glutamine. The mock (pRC3) and VHL reconstituted (WT-7) 786-O cell lines [49] were generous gifts from W.G. Kaelin Jr. (Dana Farber Cancer Institute) and were maintained in the same medium supplemented with the selective agent G418 (0.8 mg/mL Geneticin; Roche Applied Science, Life Technologies).
###end p 64
###begin p 65
###xml 156 160 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Fogh1">[36]</xref>
###xml 318 322 314 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Ebert1">[50]</xref>
For evaluation of Gas6 expression in 786-O wt cells, cells were grown in supplement of 10 microg/mL vitamin K (Konakion; Roche). The ccRCC Caki-2 cell line [36], and the ccRCC SKRC -7, -17, -21 (kindly provided by Dr. E. Oosterwijk (Radboud University Mijmegen medical Center, The Netherlands), and SKRC-52 cell lines [50] were maintained in the same medium as 786-O cells.
###end p 65
###begin p 66
In hypoxia experiments, cells were grown in 1% oxygen in a 400 Hypoxia Workstation (Ruskinn Technology Ltd.; MORTEK AS) connected to a Fuskinn gas mixer module.
###end p 66
###begin title 67
Preparation of Recombinant Gas6
###end title 67
###begin p 68
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Stenhoff1">[51]</xref>
###xml 12 17 <span type="species:ncbi:9606">human</span>
Recombinant human Gas6 was expressed and collected in serum-free OPTIMEM as described previously [51]. Monoclonal antibody affinity purified Gas6 was thereafter obtained (to be described elsewhere). In experiments where Gas6 control is designated mock, Gas6 in OPTIMEM was used for Gas6 stimulation (Gas6), and OPTIMEM harvested from mock-transfected cells as control (mock). In experiments where Gas6 control is designated TBS, purified Gas6 was used for Gas6 stimulation (Gas6), and purification buffer as control (TBS).
###end p 68
###begin title 69
Preparation of ccRCC Lysates
###end title 69
###begin p 70
###xml 61 65 61 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 795 796 795 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 17 24 <span type="species:ncbi:9606">patient</span>
Removal of ccRCC patient biopsies was performed as described [20]. To extract total protein, 200 mg of frozen biopsies were crushed with a mortar and pestle in liquid nitrogen. Powdered tissues were directly dissolved in ice-cold lysis buffer (1% Triton X-100, 25 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, and 10% glycerol supplemented with 100 mM PMSF, 200 mM Sodium Orthovanadate and the protease inhibitor cocktail set III (#539134, Calbiochem, MERCK; according to manufacturer) containing AEBSF-Hydrochloride, Aprotinin, Bestatin, E-64, Leupeptin and Pepstatin A. Suspensions were then vortexed for 1 min and thereafter incubated on ice for 45 min. Finally, the lysed suspensions were homogenized with a polytron (IKA T 8 Ultra-Turrax, IKA) at level 5 for 2x15 s, centrifugated at 20 000x g at 4degreesC for 5 min, and clear supernatants were transferred to clean tubes for storage on ice until analysis the same day (2/3 of sample was used for immunoprecipitation and the remaining sample was used for the ELISA assays).
###end p 70
###begin p 71
###xml 488 489 478 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Preparation of lysate from ccRCC cell lines was performed as follows. Adherent cells were put on ice. Medium was removed and cells were washed once in ice-cold PBS. Thereafter, ice-cold lysis buffer (1% Triton X-100, 25 mM Tris-HCl pH 7.5, 150 mM NaCl, 5 mM EDTA, and 10% glycerol supplemented with 100 mM PMSF, 200 mM Sodium Orthovanadate, and 200 microg/mL Aprotinin) was added to the plate, and lysis was allowed for 20 min with agitation at 4degreesC. After centrifugation at 20 000x g for 1 min at 4degreesC, the clear supernatants were transferred to fresh tubes and stored on ice until use on the same day for immunoprecipitation and western blot analysis.
###end p 71
###begin title 72
Immunoprecipitation
###end title 72
###begin p 73
###xml 379 380 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
###xml 778 779 744 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">g</italic>
Lysates (volume of ccRCC tissue lysates was 500 microL respectively) were pre-cleared with 10 microL pre-immune sera for 30 min at 4degreesC with rotation followed by incubation with 10 x excess protein A-Sepharose (in relation to immunoglobulin G-binding capacity; #10-1041, Invitrogen Corporation) for another 30 min. Immune complexes were removed by centrifugation at 20 000x g for 1 min at 4degreesC and the pre-cleared lysates were subsequently incubated with polyclonal antisera containing 50-100 microg total immunoglobulin molecules (about 0.5-1 microg of specific immunoprecipitating antibody) for 1 h at 4degreesC with rotation followed by incubation with 10 x excess protein A-Sepharose for another 30 min. Immune complexes were pelleted by centrifugation at 20 000x g for 1 min at 4degreesC, and washed x 2 in ice-cold lysis buffer and finally x 1 in ice-cold TBS-T (50 mM Tris-HCl pH 7.4, 150 mM NaCl and 0.1% Tween 20). The immunoprecipitated protein was released by dissolving the pellet in reducing SDS-PAGE sample buffer (200 mM Tris-HCl pH 8.8, 60% sucrose, and Bromophenol blue supplemented with dithiothreitol (DTT) to 10 mM final sample concentration).
###end p 73
###begin p 74
###xml 87 92 <span type="species:ncbi:9606">human</span>
###xml 127 133 <span type="species:ncbi:9986">rabbit</span>
###xml 193 199 <span type="species:ncbi:9986">rabbit</span>
###xml 311 317 <span type="species:ncbi:9986">rabbit</span>
Antibodies used to immunoprecipitate Axl and Gas6 from ccRCC total cell lysate or from human ccRCC biopsies, were generated as rabbit polyclonal anti-Axl (Ig-fraction of an in-house polyclonal rabbit antiserum denoted R042; towards Axl N-terminal) or anti-Gas6 antibodies (Ig-fraction of an in-house polyclonal rabbit antiserum denoted R05).
###end p 74
###begin title 75
Western Blot Analysis
###end title 75
###begin p 76
###xml 553 557 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Brown1">[52]</xref>
###xml 559 591 555 587 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">kind gift from Dr. Johan Stenflo</italic>
Protein samples were separated on an 8% SDS-PAGE gel and the proteins were transferred from the gel onto a polyvinylidene fluoride (PVDF) membrane (Pall Corporation; VWR International AB). After blocking, membranes were incubated with the following unlabeled primary antibody: anti-phosphotyrosine (pY99; sc-7020, Santa Cruz Biotechnology), anti-Axl (C-20; towards Axl C-terminal; sc-1096, Santa Cruz Biotechnology), anti-Axl (#AF154; towards Axl N-terminal, R&D Systems), anti-Gas6 (AB885, R&D Systems), anti-gamma-carboxyglutamyl acid (anti-Gla; M3b) [52], kind gift from Dr. Johan Stenflo), anti-beta-actin (A5441, Sigma-Aldrich). HRP-conjugated secondary antibodies were obtained from DAKO. Chemiluminescence was developed with Immobilon Western Chemiluminescent HRP Substrate (WBKL S0500, Millipore) and traced with Fuji LAS 3000IR CDD camera, and the signals were quantified with the Image Gauge program (FUJIFILM, Science Lab 2003, version 4.1).
###end p 76
###begin title 77
Quantitative Real-Time Reverse Transcription PCR
###end title 77
###begin p 78
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
One-step multiplex quantitative real-time reverse transcription PCR (qRT-PCR) was employed using primary tumor total RNA and matched histopathologically non-malignant kidney cortex tissue serving as a reference (commercial ccRCC tumor RNA of nuclear grade 3; Ambion). The qRT-PCR analysis was employed as described previously [20].
###end p 78
###begin title 79
ELISA Assay for the Quantification of Axl and Gas6
###end title 79
###begin p 80
###xml 214 218 214 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0007575-Gustafsson1">[20]</xref>
###xml 46 53 <span type="species:ncbi:9606">patient</span>
Concentrations of sAxl and Gas6 protein ccRCC patient material and their matched normal counterparts were estimated using in-house developed sandwich ELISA assays specific for sAxl and Gas6 as previously described [20].
###end p 80
###begin title 81
siRNA Transfection
###end title 81
###begin p 82
###xml 269 279 269 270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8482;</italic>
ccRCC 786-O cells were seeded in 60 mm plates 24 h preceding transfection. Thereafter, cells were transfected with siRNA targeting Axl (siAxl; sc-29769, Santa Cruz Biotechnology) or scrambled control siRNA (siSCR; sc-37007, Santa Cruz Biotechnology) using Lipofectaminetrade mark2000 (#11668-019, Invitrogen) in serum-free OPTIMEM (GIBCO, Invitrogen) for 5 h at 37degreesC. The medium was then replaced with conditioned DMEM containing 10% FCS and cells incubated for another 24 h. Transfected cells were then used in the Boyden chamber assay (below) to analyze their migratory and invasive capacity.
###end p 82
###begin title 83
Boyden Chamber Migration and Invasion
###end title 83
###begin p 84
###xml 484 485 478 479 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
Boyden chambers with 24-wells (Transwell(R) Permeable Supports; Cole-Parmer; BergmanLabora AB) were used to evaluate the migratory capacity of Gas6 or mock stimulated wt ccRCC 786-O cells siAxl and siSCR transfected cells. The chambers consist of an upper and lower space separated by a microporous polycarbonate membrane with a pore size of 8 microm. Membranes of each chamber were incubated in serum-free medium for an initial equilibrium period of 1 h. A cell concentration of 1x106 cells/mL was added to each migration (upper) chamber. Cells were allowed to attach for 2 h and thereafter chemotaxis was induced by addition of 10% FCS to the lower chamber. Simultaneously, 400 ng/mL Gas6 (final concentration) or mock control were added to both the upper and lower chamber and the cells were allowed to migrate from the upper compartment through the membrane towards the lower compartment along the chemoattractant gradient.
###end p 84
###begin p 85
###xml 83 89 <span type="species:ncbi:3635">cotton</span>
Migration was allowed for 4 h at 37degreesC. The chambers were then cleaned with a cotton swap with 1 x PBS to remove the cells left on top of the membranes. Migrated cells were fixed for 15 min in 4% paraformaldehyde. Membranes were cut out with a needle, put on a glass slide and finally the cells were stained with 4'6-diamidino-2-phenylindole (DAPI; Vector Laboratories Inc.; IMMUNKEMI F&D AB). Migrated cells could be counted using microscopy at 40x magnification.
###end p 85
###begin p 86
###xml 196 197 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
In the invasion assay, Boyden chambers were coated with 50 microL of 12.5% growth factor reduced matrigel (#354230, BD Bioscience) and incubated at 37degreesC for 1 h. A cell concentration of 1x106 cells/mL was added to each pre-incubated invasion chamber and cells were allowed to attach for 2 h with no chemoattractant. Thereafter, chemotaxis was induced by addition of 10% FCS to the lower chamber. Simultaneously, 400 ng/mL Gas6 (final concentration) or TBS control were added to both the upper and lower chamber and the cells were allowed under 16 h at 37degreesC to invade the matrigel and migrate. Cells were harvested as described in the migration assay. In both migration and invasion assay three representative fields were counted for each membrane and each treatment condition was assayed in triplicate and repeated three times.
###end p 86
###begin title 87
MTT Assay
###end title 87
###begin p 88
###xml 71 72 71 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
ccRCC 786-O cells were seeded in a 96-well plate at a density of 2.5x104 cells/mL for 24 h at 37degreesC. Thereafter cells were treated with 400 ng/mL Gas6 or TBS control and incubation was continued for another 24 h. Thereafter, MTT dye solution (Promega Corporation; Promega Biotech) was added and incubation continued for another 4 h. The assay was ended by addition of Stop/Lys solution (Promega Corporation) followed by incubation over night in a light-protected container at room temperature. The absorbance generated was read using the ELISA-plate (anthos 2020, anthos labtec instruments) reader at 595 nm using 690 nm as a reference.
###end p 88
###begin title 89
Statistical Analyses
###end title 89
###begin p 90
For statistical analysis comparing one condition to a normalized value, the one sample t-test to a theoretical value was used. Otherwise, when comparing different conditions within one experiment the unpaired t-test was employed. Data are presented as the mean +/- SD. All statistical tests were two-sided, and the significance level was set at 0.05. Statistical analyses were performed using the GraphPad Prism software package (version 4.0c for Macintosh).
###end p 90
###begin title 91
Supporting Information
###end title 91
###begin p 92
Gas6-stimulated ccRCC 786-O cells display a modest increase in phosphorylated Erk levels.
###end p 92
###begin p 93
(0.15 MB PDF)
###end p 93
###begin p 94
Click here for additional data file.
###end p 94
###begin p 95
###xml 132 137 <span type="species:ncbi:9606">human</span>
The authors are grateful to Mr. Carl Ekman for invaluable help with the ELISA assays, and for the kind gift of purified recombinant human Gas6.
###end p 95
###begin title 96
References
###end title 96
###begin article-title 97
Cell signaling by receptor tyrosine kinases.
###end article-title 97
###begin article-title 98
###xml 42 47 <span type="species:ncbi:9606">human</span>
The protein tyrosine kinase family of the human genome.
###end article-title 98
###begin article-title 99
Signalling and functional diversity within the Axl subfamily of receptor tyrosine kinases.
###end article-title 99
###begin article-title 100
###xml 101 106 <span type="species:ncbi:9606">human</span>
TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.
###end article-title 100
###begin article-title 101
Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily.
###end article-title 101
###begin article-title 102
Vitamin K-dependent actions of Gas6.
###end article-title 102
###begin article-title 103
The protein encoded by a growth arrest-specific gene (gas6) is a new member of the vitamin K-dependent proteins related to protein S, a negative coregulator in the blood coagulation cascade.
###end article-title 103
###begin article-title 104
###xml 74 78 <span type="species:ncbi:10090|species:ncbi:10095">mice</span>
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis.
###end article-title 104
###begin article-title 105
The second laminin G-type domain of protein S is indispensable for expression of full cofactor activity in activated protein C-catalysed inactivation of factor Va and factor VIIIa.
###end article-title 105
###begin article-title 106
Gas6, the ligand of Axl tyrosine kinase receptor, has mitogenic and survival activities for serum starved NIH3T3 fibroblasts.
###end article-title 106
###begin article-title 107
###xml 47 52 <span type="species:ncbi:9606">human</span>
axl, a transforming gene isolated from primary human myeloid leukemia cells, encodes a novel receptor tyrosine kinase.
###end article-title 107
###begin article-title 108
A novel putative tyrosine kinase receptor with oncogenic potential.
###end article-title 108
###begin article-title 109
Receptor tyrosine kinases expressed in metastatic colon cancer.
###end article-title 109
###begin article-title 110
###xml 90 95 <span type="species:ncbi:9606">human</span>
Estrogen dependent expression of the receptor tyrosine kinase axl in normal and malignant human breast.
###end article-title 110
###begin article-title 111
###xml 70 75 <span type="species:ncbi:9606">human</span>
###xml 114 122 <span type="species:ncbi:9606">patients</span>
Axl and growth arrest-specific gene 6 are frequently overexpressed in human gliomas and predict poor prognosis in patients with glioblastoma multiforme.
###end article-title 111
###begin article-title 112
###xml 50 55 <span type="species:ncbi:9606">human</span>
Expression of the Axl receptor tyrosine kinase in human thyroid carcinoma.
###end article-title 112
###begin article-title 113
Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway.
###end article-title 113
###begin article-title 114
Protein kinases in normal and transformed melanocytes.
###end article-title 114
###begin article-title 115
Expression of axl in lung adenocarcinoma and correlation with tumor progression.
###end article-title 115
###begin article-title 116
Differential Expression of Axl and Gas6 in Renal Cell Carcinoma Reflecting Tumor Advancement and Survival.
###end article-title 116
###begin article-title 117
Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival.
###end article-title 117
###begin article-title 118
Multiple roles for the receptor tyrosine kinase axl in tumor formation.
###end article-title 118
###begin article-title 119
Renal cell carcinoma guideline.
###end article-title 119
###begin article-title 120
Renal-cell carcinoma.
###end article-title 120
###begin article-title 121
###xml 50 55 <span type="species:ncbi:9606">human</span>
Growth arrest specific protein 6/Axl signaling in human inflammatory renal diseases.
###end article-title 121
###begin article-title 122
Role of growth arrest-specific gene 6 in diabetic nephropathy.
###end article-title 122
###begin article-title 123
Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy.
###end article-title 123
###begin article-title 124
Gas6 regulates mesangial cell proliferation through Axl in experimental glomerulonephritis.
###end article-title 124
###begin article-title 125
Essential role of Gas6 for glomerular injury in nephrotoxic nephritis.
###end article-title 125
###begin article-title 126
Axl receptor tyrosine kinase stimulated by the vitamin K-dependent protein encoded by growth-arrest-specific gene 6.
###end article-title 126
###begin article-title 127
The transforming receptor tyrosine kinase, Axl, is post-translationally regulated by proteolytic cleavage.
###end article-title 127
###begin article-title 128
The role of gamma-carboxylation in the anti-apoptotic function of gas6.
###end article-title 128
###begin article-title 129
Axl promotes cell invasion by inducing MMP-9 activity through activation of NF-kappaB and Brg-1.
###end article-title 129
###begin article-title 130
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis.
###end article-title 130
###begin article-title 131
Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.
###end article-title 131
###begin article-title 132
###xml 53 58 <span type="species:ncbi:9606">human</span>
Cultivation, characterization, and identification of human tumor cells with emphasis on kidney, testis, and bladder tumors.
###end article-title 132
###begin article-title 133
###xml 28 33 <span type="species:ncbi:9606">human</span>
Coexpression of Gas6/Axl in human ovarian cancers.
###end article-title 133
###begin article-title 134
AXL is a potential target for therapeutic intervention in breast cancer progression.
###end article-title 134
###begin article-title 135
###xml 44 49 <span type="species:ncbi:9606">human</span>
Growth arrest-specific gene 6 expression in human breast cancer.
###end article-title 135
###begin article-title 136
GAS6 induces Axl-mediated chemotaxis of vascular smooth muscle cells.
###end article-title 136
###begin article-title 137
Novel mechanism for gonadotropin-releasing hormone neuronal migration involving Gas6/Ark signaling to p38 mitogen-activated protein kinase.
###end article-title 137
###begin article-title 138
Adhesion-related kinase induction of migration requires phosphatidylinositol-3-kinase and ras stimulation of rac activity in immortalized gonadotropin-releasing hormone neuronal cells.
###end article-title 138
###begin article-title 139
Growth arrest-specific gene 6 is involved in glomerular hypertrophy in the early stage of diabetic nephropathy.
###end article-title 139
###begin article-title 140
Inhibition of vascular endothelial growth factor receptor 2-mediated endothelial cell activation by Axl tyrosine kinase receptor.
###end article-title 140
###begin article-title 141
The receptor tyrosine kinase ARK mediates cell aggregation by homophilic binding.
###end article-title 141
###begin article-title 142
###xml 43 48 <span type="species:ncbi:9606">human</span>
Axl receptor tyrosine kinase expression in human lung cancer cell lines correlates with cellular adhesion.
###end article-title 142
###begin article-title 143
A promiscuous liaison between IL-15 receptor and Axl receptor tyrosine kinase in cell death control.
###end article-title 143
###begin article-title 144
###xml 24 29 <span type="species:ncbi:9606">human</span>
In vitro cultivation of human renal cell cancer. II. Characterization of cell lines.
###end article-title 144
###begin article-title 145
###xml 26 31 <span type="species:ncbi:9606">human</span>
Tumour suppression by the human von Hippel-Lindau gene product.
###end article-title 145
###begin article-title 146
###xml 38 43 <span type="species:ncbi:9606">human</span>
Establishment and characterization of human renal cancer and normal kidney cell lines.
###end article-title 146
###begin article-title 147
Vitamin K-dependent Gas6 activates ERK kinase and stimulates growth of cardiac fibroblasts.
###end article-title 147
###begin article-title 148
Identification and purification of vitamin K-dependent proteins and peptides with monoclonal antibodies specific for gamma -carboxyglutamyl (Gla) residues.
###end article-title 148
###begin article-title 149
###xml 0 82 0 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">International Union Against Cancer (UICC). TNM Classification of Malignant Tumours</italic>
International Union Against Cancer (UICC). TNM Classification of Malignant Tumours. 6 ed.
###end article-title 149
###begin article-title 150
Diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases.
###end article-title 150
###begin p 151
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 151
###begin p 152
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This study was supported by grants from the Swedish Cancer Foundation, the Swedish Research Council (#07143), the Cancer Research Foundation at the University Hospital Malmke Wiberg's Foundation, Ollie and Elof Ericsson's Foundation, the Crafoord Foundation, Gunnar Nilssons Cancer Foundation, and The Royal Physiographic Society in Lund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 152

